Flow Cytometry Market

Flow Cytometry Market (Technology: Cell-based and Bead-based; and Products & Services: Reagents & Consumables, Flow Cytometry Instruments, Software, and Services) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Flow Cytometry Market Outlook 2031

  • The global industry was valued at US$ 4.4 Bn in 2022
  • It is estimated to grow at a CAGR of 8.0% from 2023 to 2031 and reach US$ 8.8 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of chronic disorders and increase in investment in clinical research are propelling the flow cytometry market trajectory. Flow cytometry is gaining traction in stem cell research to examine the characteristics of mixed cell populations derived from peripheral blood, bone marrow, and solid tissues.

Data interpretation, standardization issues, and high cost associated with advanced flow cytometry equipment are expected to lead to flow cytometry market limitations. R&D of new drugs is likely to offer lucrative opportunities to vendors in the global flow cytometry industry. Key players are investing in advanced technologies and launching new products to expand their portfolio.

Flow Cytometry Market

Market Introduction

Flow cytometry is a technology that is employed in biology and medicine to analyze and sort cells based on their physical and chemical properties. It involves the passage of cells through a laser beam, measuring the scattered and fluorescent light to identify and quantify characteristics such as size and complexity. Using microscopy, about six parameters of a single cell can be detected, whereas flow cytometer instruments can detect up to 30 distinct parameters. Additionally, modern flow cytometers are capable of processing over 10,000 cells per second, thereby, enabling scientists to rapidly analyze and characterize millions of cells.

Rise in Prevalence of Chronic Disorders Augmenting Flow Cytometry Market Size

Flow cytometry plays a major role in diagnosing and finding early signs of immune deficiencies and cancer in patients. Immunophenotyping, biomarker analysis, and disease monitoring are some of the techniques utilized to determine severe chronic conditions.

Surge in prevalence of chronic diseases, such as leishmaniasis, HIV, and cancer amongst individuals is fueling the flow cytometry market development. According to the World Health Organization, cancer was one of the leading causes of death in 2020, accounting for approximately 10 million deaths. The most common types of cancer were breast cancer (2.26 million cases), lung cancer (2.21 million cases), colon and rectum cancer (1.93 million cases), prostate (1.41 million cases), skin (1.20 million cases), and stomach (1.09 million cases).

In April 2022, an article published in the journal Biochemistry Research International stated that Visceral Leishmaniasis (VL), also referred to as kala-azar, affects around 50,000-90,000 individuals globally every year. Thus, high incidence of VL is expected to spur the flow cytometry market growth in the near future. In December 2022, an article published in the journal Tropical Medicine and Infectious Disease discussed how the number of cases of leishmaniasis has been rising over the past five years. Flow cytometry in infectious disease diagnosis is employed to analyze and characterize cells, typically blood cells, to identify and quantify pathogens or abnormal immune responses associated with infections.

Rise in application of flow cytometry in stem cell research is propelling the market revenue. In April 2022, the International Journal of Laboratory Haematology published an article discussing the versatile applications of flow cytometry in examining the characteristics of mixed cell populations derived from peripheral blood (PB), bone marrow (BM), and solid tissues. This method enables the isolation of individual cells for further study.

Increase in Investment in Clinical Research Boosting Market Progress

Flow cytometry is an analytical method utilized in the detection and analysis of physical features of cells or particles during the drug discovery and development process. It has emerged as an important tool for safety and exploratory purposes due to its ability to quickly examine a large number of particles and provide statistically reliable information on the cell population.

R&D of new drugs is driving the flow cytometry market revenue. The need for developing new drugs has led to surge in investment in clinical research. In October 2021, BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Company), collaborated with Christian Medical College (CMC), Vellore, to launch its second Centre of Excellence (CoE) in flow cytometry for clinical research in India. This CoE is expected to serve as the National Reference Center for clinical diagnostics applications, wherein hematologists, physicians, and lab specialists from across India can come together to deliberate and discuss standardization and the best practices in clinical flow cytometry, according to BD Life Sciences.

Availability of digital platform for flow cytometry is fueling the flow cytometry market value.

In July 2021, Becton, Dickinson, and Company introduced a reimagined digital platform for flow cytometry to enhance the online shopping experience for its consumers and procurement teams. The new BD Biosciences marketplace is an online destination that offers BD's research, clinical, and single-cell analysis, and multi-omic products, making it an attractive option for the most in-depth users of flow cytometry.

Regional Outlook

North America accounted for the largest flow cytometry market share in 2022, led by a rise in leishmaniasis and HIV cases. The increasing prevalence of leishmaniasis and HIV has highlighted the significance of flow cytometry in determining a patient's prognosis. In July 2022, the Government of Canada estimated 62,790 people were living with HIV in Canada from 2020 to 2021. Presence of major players is also driving the market dynamics of North America.

Analysis of Key Players

The global flow cytometry market landscape is highly competitive, with several opportunities for expansion and innovation. Flow cytometry companies are adopting various strategies, such as mergers and acquisitions and new product development, to expand their product portfolio.

Becton, Dickinson and Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Sysmex Corporation, Abbott, Miltenyi Biotec, Bio-Techne, Agilent Technologies, Inc., and Bio-Rad Laboratories, Inc. are some of the key players operating in this market.

Each of these companies has been profiled in the flow cytometry market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.

Key Developments

  • In September 2022, Becton, Dickinson, and Company, a leading global medical technology company, launched BD Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher-quality experiments with faster time to insight for scientists working across a range of disciplines including immunology, virology, oncology, and infectious disease monitoring.
  • In March 2021, Beckman Coulter introduced the CytoFLEX platform that can easily provide multicolor applications, resulting in broadening the technology's laser and color options

Flow Cytometry Market Snapshot

Attribute Detail
Market Size in 2022 US$ 4.4 Bn
Market Forecast (Value) in 2031 US$ 8.8 Bn
Growth Rate (CAGR) 8.0%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • By Technology
    • Cell-based
    • Bead-based
  • By Products & Services
    • Reagents & Consumables
    • Flow Cytometry Instruments
      • Cell Analyzers
      • Cell Sorters
    • Software
    • Services
  • By Application
    • Pharmaceutical & Drug Discovery
    • Diagnostics
    • Others
  • By End-user
    • Hospitals & Diagnostic Labs
    • Academic & Research Institutions
    • Others
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia and CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC
  • South Africa
Companies Profiled
  • Becton, Dickinson and Company
  • Merck & Co., Inc.
  • Beckman Coulter, Inc.
  • Sysmex Corporation
  • Abbott
  • Miltenyi Biotec
  • Bio-Techne
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global flow cytometry market in 2022?

It was valued at US$ 4.4 Bn in 2022

How is the flow cytometry industry expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 8.0% from 2023 to 2031

What are the key factors driving the demand for flow cytometry?

Rise in prevalence of chronic disorders and increase in investment in clinical research

Which was the major region in the global flow cytometry landscape in 2022?

North America was the leading region in 2022

Who are the prominent flow cytometry manufacturers?

Becton, Dickinson and Company, Merck & Co., Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Sysmex Corporation, Abbott, Miltenyi Biotec, Bio-Techne, Agilent Technologies, Inc., and Bio-Rad Laboratories, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Flow Cytometry Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Technology Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Flow Cytometry Market Analysis and Forecast, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Technology/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Flow Cytometry Market Analysis and Forecast, by Technology

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Technology, 2017–2031

            6.3.1. Cell-based

            6.3.2. Bead-based

        6.4. Market Attractiveness, by Technology

    7. Global Flow Cytometry Market Analysis and Forecast, by Products & Services

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Products & Services, 2017–2031

            7.3.1. Reagents & Consumables

            7.3.2. Flow Cytometry Instruments

                7.3.2.1. Cell Analyzers

                7.3.2.2. Cell Sorters

            7.3.3. Software

            7.3.4. Services

            7.3.5. 7.4 Market Attractiveness, by Products & Services

    8. Global Flow Cytometry Market Analysis and Forecast, by Application

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Application, 2017–2031

            8.3.1. Pharmaceutical & Drug Discovery

            8.3.2. Diagnostics

            8.3.3. Others

        8.4. Market Attractiveness, by Application

    9. Global Flow Cytometry Market Analysis and Forecast, by End-user

        9.1. Introduction and Definitions

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals & Diagnostic Labs

            9.3.2. Academic & Research Institutions

            9.3.3. Others

        9.4. Market Attractiveness, by End-user

    10. Global Flow Cytometry Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region, 2017–2031

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness, by Region

    11. North America Flow Cytometry Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Technology, 2017–2031

            11.2.1. Cell-based

            11.2.2. Bead-based

        11.3. Market Attractiveness, by Technology

        11.4. Market Value Forecast, by Products & Services, 2017–2031

            11.4.1. Reagents & Consumables

            11.4.2. Flow Cytometry Instruments

                11.4.2.1. Cell Analyzers

                11.4.2.2. Cell Sorters

            11.4.3. Software

            11.4.4. Services

        11.5. Market Attractiveness, by Products & Services

        11.6. Market Value Forecast, by Application, 2017–2031

            11.6.1. Pharmaceutical & Drug Discovery

            11.6.2. Diagnostics

            11.6.3. Others

        11.7. Market Attractiveness, by Application

        11.8. Market Value Forecast, by End-user, 2017–2031

            11.8.1. Hospitals & Diagnostic Labs

            11.8.2. Academic & Research Institutions

            11.8.3. Others

        11.9. Market Attractiveness, by End-user

        11.10. Market Value Forecast, by Country, 2017–2031

            11.10.1. U.S.

            11.10.2. Canada

        11.11. Market Attractiveness Analysis

            11.11.1. By Technology

            11.11.2. By Products & Services

            11.11.3. By Application

            11.11.4. By End-user

            11.11.5. By Country

    12. Europe Flow Cytometry Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Technology, 2017–2031

            12.2.1. Cell-based

            12.2.2. Bead-based

        12.3. Market Attractiveness, by Technology

        12.4. Market Value Forecast, by Products & Services, 2017–2031

            12.4.1. Reagents & Consumables

            12.4.2. Flow Cytometry Instruments

                12.4.2.1. Cell Analyzers

                12.4.2.2. Cell Sorters

            12.4.3. Software

            12.4.4. Services

        12.5. Market Attractiveness, by Products & Services

        12.6. Market Value Forecast, by Application, 2017–2031

            12.6.1. Pharmaceutical & Drug Discovery

            12.6.2. Diagnostics

            12.6.3. Others

        12.7. Market Attractiveness, by Application

        12.8. Market Value Forecast, by End-user, 2017–2031

            12.8.1. Hospitals & Diagnostic Labs

            12.8.2. Academic & Research Institutions

            12.8.3. Others

        12.9. Market Attractiveness, by End-user

        12.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.10.1. Germany

            12.10.2. U.K.

            12.10.3. France

            12.10.4. Italy

            12.10.5. Spain

            12.10.6. Rest of Europe

        12.11. Market Attractiveness Analysis

            12.11.1. By Technology

            12.11.2. By Products & Services

            12.11.3. By Application

            12.11.4. By End-user

            12.11.5. By Country/Sub-region

    13. Asia Pacific Flow Cytometry Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Technology, 2017–2031

            13.2.1. Cell-based

            13.2.2. Bead-based

        13.3. Market Attractiveness, by Technology

        13.4. Market Value Forecast, by Products & Services, 2017–2031

            13.4.1. Reagents & Consumables

            13.4.2. Flow Cytometry Instruments

                13.4.2.1. Cell Analyzers

                13.4.2.2. Cell Sorters

            13.4.3. Software

            13.4.4. Services

        13.5. Market Attractiveness, by Products & Services

        13.6. Market Value Forecast, by Application, 2017–2031

            13.6.1. Pharmaceutical & Drug Discovery

            13.6.2. Diagnostics

            13.6.3. Others

        13.7. Market Attractiveness, by Application

        13.8. Market Value Forecast, by End-user, 2017–2031

            13.8.1. Hospitals & Diagnostic Labs

            13.8.2. Academic & Research Institutions

            13.8.3. Others

        13.9. Market Attractiveness, by End-user

        13.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.10.1. China

            13.10.2. Japan

            13.10.3. India

            13.10.4. Australia & New Zealand

            13.10.5. Rest of Asia Pacific

        13.11. Market Attractiveness Analysis

            13.11.1. By Technology

            13.11.2. By Products & Services

            13.11.3. By Application

            13.11.4. By End-user

            13.11.5. By Country/Sub-region

    14. Latin America Flow Cytometry Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Technology, 2017–2031

            14.2.1. Cell-based

            14.2.2. Bead-based

        14.3. Market Attractiveness, by Technology

        14.4. Market Value Forecast, by Products & Services, 2017–2031

            14.4.1. Reagents & Consumables

            14.4.2. Flow Cytometry Instruments

                14.4.2.1. Cell Analyzers

                14.4.2.2. Cell Sorters

            14.4.3. Software

            14.4.4. Services

        14.5. Market Attractiveness, by Products & Services

        14.6. Market Value Forecast, by Application, 2017–2031

            14.6.1. Pharmaceutical & Drug Discovery

            14.6.2. Diagnostics

            14.6.3. Others

        14.7. Market Attractiveness, by Application

        14.8. Market Value Forecast, by End-user, 2017–2031

            14.8.1. Hospitals & Diagnostic Labs

            14.8.2. Academic & Research Institutions

            14.8.3. Others

        14.9. Market Attractiveness, by End-user

        14.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.10.1. Brazil

            14.10.2. Mexico

            14.10.3. Rest of Latin America

        14.11. Market Attractiveness Analysis

            14.11.1. By Technology

            14.11.2. By Products & Services

            14.11.3. By Application

            14.11.4. By End-user

            14.11.5. By Country/Sub-region

    15. Middle East & Africa Flow Cytometry Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Technology, 2017–2031

            15.2.1. Cell-based

            15.2.2. Bead-based

        15.3. Market Attractiveness, by Technology

        15.4. Market Value Forecast, by Products & Services, 2017–2031

            15.4.1. Reagents & Consumables

            15.4.2. Flow Cytometry Instruments

                15.4.2.1. Cell Analyzers

                15.4.2.2. Cell Sorters

            15.4.3. Software

            15.4.4. Services

        15.5. Market Attractiveness, by Products & Services

        15.6. Market Value Forecast, by Application, 2017–2031

            15.6.1. Pharmaceutical & Drug Discovery

            15.6.2. Diagnostics

            15.6.3. Others

        15.7. Market Attractiveness, by Application

        15.8. Market Value Forecast, by End-user, 2017–2031

            15.8.1. Hospitals & Diagnostic Labs

            15.8.2. Academic & Research Institutions

            15.8.3. Others

        15.9. Market Attractiveness, by End-user

        15.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.10.1. GCC Countries

            15.10.2. South Africa

            15.10.3. Rest of Middle East & Africa

        15.11. Market Attractiveness Analysis

            15.11.1. By Technology

            15.11.2. By Products & Services

            15.11.3. By Application

            15.11.4. By End-user

            15.11.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        16.2. Market Share Analysis, by Company (2022)

        16.3. Company Profiles

            16.3.1. Becton, Dickinson and Company

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Merck & Co., Inc.

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Beckman Coulter, Inc.

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. Sysmex Corporation

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Abbott

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. Miltenyi Biotec

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. Bio-Techne

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Agilent Technologies, Inc.

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. Bio-Rad Laboratories, Inc.

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Thermo Fisher Scientific

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. Financial Overview

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 02: Global Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 03: Global Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 05: Global Flow Cytometry Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Flow Cytometry Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 08: North America Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 09: North America Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 10: North America Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 11: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 12: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 13: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 14: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: Europe Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 18: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 19: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Asia Pacific Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 23: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 24: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 25: Latin America Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 26: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 27: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 28: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 29: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 30: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Flow Cytometry Market Size (US$ Mn), by Region, 2022 and 2031

    Figure 02: Global Flow Cytometry Market Revenue (US$ Mn), by Technology, 2022

    Figure 03: Global Flow Cytometry Market Value Share, by Technology, 2022

    Figure 04: Global Flow Cytometry Market Revenue (US$ Mn), by Products & Services, 2022

    Figure 05: Global Flow Cytometry Market Value Share, by Products & Services, 2022

    Figure 06: Global Flow Cytometry Market Revenue (US$ Mn), by Application, 2022

    Figure 07: Global Flow Cytometry Market Value Share, by Application, 2022

    Figure 08: Global Flow Cytometry Market Revenue (US$ Mn), by End-user, 2022

    Figure 09: Global Flow Cytometry Market Value Share, by End-user, 2022

    Figure 10: Global Flow Cytometry Market Value Share, by Region, 2022

    Figure 11: Global Flow Cytometry Market Value (US$ Mn) Forecast, 2017–2031

    Figure 12: Global Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 13: Global Flow Cytometry Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 14: Global Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 15: Global Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023-2031

    Figure 16: Global Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031

    Figure 17: Global Flow Cytometry Market Attractiveness Analysis, by Application, 2023-2031

    Figure 18: Global Flow Cytometry Market Revenue (US$ Mn), by End-user, 2022

    Figure 19: Global Flow Cytometry Market Value Share, by End-user, 2022

    Figure 20: Global Flow Cytometry Market Value Share Analysis, by Region, 2022 and 2031

    Figure 21: Global Flow Cytometry Market Attractiveness Analysis, by Region, 2023-2031

    Figure 22: North America Flow Cytometry Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 23: North America Flow Cytometry Market Attractiveness Analysis, by Country, 2023–2031

    Figure 24: North America Flow Cytometry Market Value Share Analysis, by Country, 2022 and 2031

    Figure 25: North America Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 26: North America Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 27: North America Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031

    Figure 28: North America Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 29: North America Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 30: North America Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 31: North America Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031

    Figure 32: North America Flow Cytometry Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 33: Europe Flow Cytometry Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 34: Europe Flow Cytometry Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 35: Europe Flow Cytometry Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 36: Europe Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 37: Europe Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 38: Europe Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031

    Figure 39: Europe Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 40: Europe Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 41: Europe Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 42: Europe Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031

    Figure 43: Europe Flow Cytometry Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 44: Asia Pacific Flow Cytometry Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 45: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 46: Asia Pacific Flow Cytometry Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 47: Asia Pacific Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 48: Asia Pacific Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 49: Asia Pacific Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031

    Figure 50: Asia Pacific Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 51: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 52: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 53: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031

    Figure 54: Asia Pacific Flow Cytometry Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 55: Latin America Flow Cytometry Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 56: Latin America Flow Cytometry Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 57: Latin America Flow Cytometry Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 58: Latin America Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 59: Latin America Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 60: Latin America Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031

    Figure 61: Latin America Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 62: Latin America Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 63: Latin America Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 64: Latin America Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031

    Figure 65: Latin America Flow Cytometry Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 66: Middle East & Africa Flow Cytometry Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 67: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 68: Middle East & Africa Flow Cytometry Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 69: Middle East & Africa Flow Cytometry Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 70: Middle East & Africa Flow Cytometry Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 71: Middle East & Africa Flow Cytometry Market Value Share Analysis, by Application, 2022 and 2031

    Figure 72: Middle East & Africa Flow Cytometry Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 73: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 74: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 75: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by Application, 2023–2031

    Figure 76: Middle East & Africa Flow Cytometry Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved